Literature DB >> 23126524

Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.

Wilko F A R Verbakel1, Jaap van den Berg, Ben J Slotman, Peter Sminia.   

Abstract

PURPOSE: Investigation of clonogenic cell survival and cell proliferation following single dose and fractionated delivery of high dose rate flattening filter free (FFF) irradiation compared to conventional dose rates.
MATERIAL AND METHODS: The human astrocytoma D384, glioma T98 and lung carcinoma SW1573 cell lines were irradiated using either a single dose (0-12 Gy) or a fractionated protocol of 5 daily fractions of 2 Gy (D384) or 3 Gy (SW1573). Cells were irradiated inside a phantom using fixed gantry beams of a linear accelerator. A sliding window technique created homogeneous dose distributions over the surface of the cell cultures. Irradiations using standard beams (6 MV, 600 MU/min.) and high dose rate FFF beams (10 MV, 2400 MU/min.) were compared. Cell survival was determined by clonogenic assay. In the fractionated irradiation set-up, the number of clonogenic cells was estimated by including tumor cell proliferation during the overall treatment time in the analysis.
RESULTS: All cell lines showed equal cell survival following irradiation using either the FFF beams or conventional flattened (FF) beams. This was observed after single dose exposure (0-12 Gy) as well as after fractionated irradiation (p = 0.08 for D384 and 0.20 for SW1373 cell lines).
CONCLUSION: FFF irradiation with a dose rate of 2400 MU/min and four times higher dose per pulse compared to irradiation with FF beams did not change cell survival for three human cancer cell lines up to a fraction dose of 12 Gy compared to irradiation using FF beams.

Entities:  

Mesh:

Year:  2012        PMID: 23126524     DOI: 10.3109/0284186X.2012.737021

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

1.  Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines.

Authors:  Caroline Steenken; Jens Fleckenstein; Stefan Kegel; Lennart Jahnke; Anna Simeonova; Linda Hartmann; Jens Kübler; Marlon R Veldwijk; Frederik Wenz; Carsten Herskind; Frank Anton Giordano
Journal:  Strahlenther Onkol       Date:  2015-03-13       Impact factor: 3.621

2.  Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival.

Authors:  G Lasio; M Guerrero; W Goetz; F Lima; J E Baulch
Journal:  Radiat Environ Biophys       Date:  2014-08-29       Impact factor: 1.925

3.  Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.

Authors:  Anna Simeonova-Chergou; Anika Jahnke; Kerstin Siebenlist; Florian Stieler; Sabine Mai; Judit Boda-Heggemann; Frederik Wenz; Frank Lohr; Lennart Jahnke
Journal:  Strahlenther Onkol       Date:  2016-01-15       Impact factor: 3.621

4.  Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam.

Authors:  Chao Ge; Huidong Wang; Kunzhi Chen; Wuji Sun; Huicheng Li; Yinghua Shi
Journal:  Strahlenther Onkol       Date:  2022-04-29       Impact factor: 4.033

5.  Time motion study to evaluate the impact of flattening filter free beam on overall treatment time for frameless intracranial radiosurgery using Varian TrueBeam® linear accelerator.

Authors:  Gopinath Mamballikalam; S Senthilkumar; C O Clinto; P M Ahamed Basith; R C Jaon Bos; Tems Thomas
Journal:  Rep Pract Oncol Radiother       Date:  2021-02-25

6.  Quantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cells.

Authors:  Mi-Hyoung Kim; Seung-Youn Jung; Jiyeon Ahn; Sang-Gu Hwang; Hee-Jong Woo; Sungkwan An; Seon Young Nam; Dae-Seog Lim; Jie-Young Song
Journal:  Cell Biosci       Date:  2015-02-03       Impact factor: 7.133

7.  Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.

Authors:  Brendan M Prendergast; Michael C Dobelbower; James A Bonner; Richard A Popple; Craig J Baden; Douglas J Minnich; Robert J Cerfolio; Sharon A Spencer; John B Fiveash
Journal:  Radiat Oncol       Date:  2013-11-20       Impact factor: 3.481

8.  Safety of high-dose-rate stereotactic body radiotherapy.

Authors:  Sonja Stieb; Stephanie Lang; Claudia Linsenmeier; Shaun Graydon; Oliver Riesterer
Journal:  Radiat Oncol       Date:  2015-01-23       Impact factor: 3.481

9.  mARC Treatment of Hypopharynx Carcinoma with Flat and Flattening-Filter-Free Beam Energies - A Planning Study.

Authors:  Katharina Bell; Jochen Fleckenstein; Frank Nuesken; Norbert Licht; Christian Rübe; Yvonne Dzierma
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

Review 10.  Can high dose rates used in cancer radiotherapy change therapeutic effectiveness?

Authors:  Maria Konopacka; Jacek Rogoliński; Aleksander Sochanik; Krzysztof Ślosarek
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.